EMA — authorised 24 May 2013
- Marketing authorisation holder: Gilead Sciences Ireland UC
- Status: approved
🇪🇺 Vitekta in European Union
EMA authorised Vitekta on 24 May 2013
Marketing authorisation
Vitekta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Vitekta approved in European Union?
Yes. EMA authorised it on 24 May 2013.
Who is the marketing authorisation holder for Vitekta in European Union?
Gilead Sciences Ireland UC holds the EU marketing authorisation.